The company reported a net loss of $205 million, or 79 cents per share, according to the latest financial filing. This represents a significant downturn from the $109 million profit, or 42 cents per share, reported during the same period the previous year.

Revenue and Earnings Performance

On an adjusted basis, Organon earned 63 cents per share. This figure missed the 73 cents per share consensus estimate from analysts polled by FactSet. Revenue for the quarter also slipped, falling 5% to $1.51 billion, compared to the $1.53 billion anticipated by Wall Street.

The market reaction was immediate, with the stock price dropping to $6.67. Following this latest retreat, Organon shares have now declined 55% over the past year as the company continues to navigate post-spinoff volatility.